Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
EHR features & updates

Chemical peel consent form: Essential guidelines

Key Takeaways

Key Takeaways

A chemical peel consent form documents patient understanding of procedure risks, benefits, contraindications, and aftercare requirements.

Must include contraindication screening (tretinoin, isotretinoin, pregnancy), risk disclosures (hyperpigmentation, sensitivity), and post-treatment care instructions.

Patients on Accutane require 6-12 month washout before chemical peels; active tretinoin use is a temporary contraindication.

Pabau’s digital forms and e-signature features allow clinics to deliver, collect, and store consent forms securely with full GDPR and HIPAA audit trails.

A ready-to-use consent form covering patient details, contraindication screening (tretinoin, Accutane, pregnancy), risk disclosures (hyperpigmentation, erythema, sensitivity), aftercare acknowledgement, and signature blocks.

Download template

Most aesthetic clinics start with generic consent forms or no structured consent process at all. The result: incomplete contraindication screening, unclear risk communication, and exposure to liability if a patient experiences unexpected side effects.

A chemical peel consent form fixes this by documenting that patients understand the procedure, acknowledge known risks (hyperpigmentation, erythema, peeling), confirm they are not using contraindicated medications (tretinoin, Accutane, adapalene), and agree to follow post-treatment aftercare instructions.

This guide covers what a chemical peel consent form must include, how to complete it during patient intake, how to store signed forms securely, and how practice management software streamlines the entire process.

A chemical peel consent form is a signed document that confirms a patient understands the procedure, acknowledges potential risks, confirms they are not contraindicated for treatment, and agrees to follow aftercare instructions.

The form serves two critical functions: it protects the clinic by demonstrating informed consent (reducing liability if complications arise), and it protects the patient by ensuring they receive clear information about what to expect before, during, and after treatment.

According to the American Society of Plastic Surgeons (ASPS), informed consent for aesthetic procedures must address the procedure’s benefits, risks, alternatives, and expected recovery timeline. A chemical peel consent form must align with these standards.

In the UK, the Information Commissioner’s Office (ICO) requires that signed consent forms be stored securely under GDPR. Patient consent documents are sensitive personal data and must be protected with appropriate technical and organisational safeguards.

Using a chemical peel consent form in your clinic workflow requires integrating it into patient intake and ensuring patients read, understand, and sign it before treatment begins.

  1. Distribute the form at the initial consultation. Provide the digital form template via email or patient portal at least 24 hours before the appointment. This gives patients time to review contraindications and medication history questions.
  2. Review contraindication screening sections. Have the patient confirm they are not currently using tretinoin, Accutane (isotretinoin), adapalene (Differin), or other retinoids; are not pregnant or breastfeeding; have not had recent laser or filler treatments; and do not have active cold sores or herpes simplex infection.
  3. Discuss specific risks for the peel type. Explain whether they are receiving a superficial (glycolic/lactic acid), medium-depth (TCA), or deep peel (phenol). Each carries different risks: superficial peels may cause mild erythema and flaking; medium-depth peels can cause hyperpigmentation in darker skin types; deep peels carry risk of scarring and require extended recovery.
  4. Confirm aftercare acknowledgement. Review the form’s aftercare instructions (avoiding sun exposure, using sunscreen SPF 30+, gentle cleansing, avoiding active ingredients for 1-2 weeks) and have the patient confirm they understand and agree to follow them.
  5. Obtain e-signature and store securely. Collect the signed form digitally using clinic software with e-signature capability. File it in the patient’s secure medical record with an audit trail showing when it was signed and by whom.

The consent process should feel educational, not like a legal checkbox. Walk through each section, answer questions, and allow the patient to voice concerns before they sign.

Any clinic offering chemical peels should use a consent form. This includes dermatology practices, medical spas, aesthetic clinics, plastic surgery offices, and esthetician-led skin clinics.

  • Medical spas and aesthetic clinics administer peels daily; consent forms document informed consent and reduce post-treatment liability disputes.
  • Dermatology practices may use peels as part of acne treatment or photoaging management; dermatology-specific consent forms reference clinical indications and expected outcomes.
  • Plastic surgery offices use consent forms as part of comprehensive facial rejuvenation plans, often combining peels with fillers or other procedures.
  • Esthetician-led clinics offering superficial glycolic or lactic acid peels must document informed consent even for lower-risk procedures, per state licensing boards and professional standards (ASCP – Associated Skin Care Professionals).
  • Multi-location chains benefit from standardized consent forms across all locations, ensuring consistent risk communication and compliance documentation.

Reduces liability and regulatory risk. A signed consent form demonstrates that the clinic obtained informed consent before treatment. If a patient experiences post-inflammatory hyperpigmentation or prolonged erythema, the form proves the clinic disclosed these risks in advance.

Screens contraindications before treatment. The form’s contraindication section identifies patients on tretinoin, Accutane, or other medications that increase peel sensitivity or risk. Catching these before the procedure prevents adverse reactions and rescheduling delays.

Clarifies aftercare expectations. Patients often disregard verbal aftercare instructions. A signed form documents that the clinic explained post-peel care (sun avoidance, gentle cleansing, sunscreen use) and that the patient acknowledged responsibility for following it.

Simplifies compliance audits. The UK’s Care Quality Commission (CQC) and ICO expect clinics to hold evidence of informed consent for aesthetic procedures. Digital compliance documentation makes inspection-readiness straightforward.

HIPAA compliance in Pabau
HIPAA compliance in Pabau.

Supports patient autonomy. Patients appreciate transparency about risks and recovery. A detailed consent form builds trust by showing the clinic takes informed consent seriously.

Simplify consent form workflows with Pabau

Deliver digital consent forms to patients, collect e-signatures, and store signed documents with full audit trails and GDPR compliance.

Pabau clinic software dashboard

Essential aftercare instructions for chemical peel recovery

Aftercare directly determines outcome quality. A chemical peel consent form must include clear, specific aftercare instructions; patients who ignore them risk prolonged erythema, hyperpigmentation, or infection.

Immediate post-peel care (Days 1-3): Patients should expect redness, mild swelling, and tight sensation. Advise gentle cleansing with lukewarm water and fragrance-free cleanser, avoiding hot water and vigorous scrubbing. Apply hydrating moisturizer immediately after cleansing and reapply multiple times daily. Avoid makeup, retinoids, vitamin C serums, and active ingredients for at least 3-5 days.

Sun protection (Days 1-14+): Chemical peels thin the stratum corneum, making skin extremely photosensitive. Require SPF 30+ broad-spectrum sunscreen daily for at least two weeks. Recommend mineral sunscreens (zinc oxide, titanium dioxide) over chemical sunscreens, which may irritate healing skin. Advise patients to avoid direct sun exposure, use a wide-brimmed hat and sunglasses, and limit outdoor time during peak hours (10am-4pm).

Avoiding common mistakes: Patients often attempt chemical exfoliants, benzoyl peroxide, or vitamin A products during healing, thinking they are “helping” recovery. The consent form should explicitly prohibit these for 1-2 weeks post-peel to prevent irritation and hyperpigmentation.

Document these instructions in the consent form and consider sending a follow-up automated aftercare email 24 hours post-treatment as a reminder.

SMS Broadcast
SMS Broadcast.

Key contraindications and screening criteria

A chemical peel consent form must include contraindication screening to identify patients at increased risk of complications. These fall into three tiers: absolute contraindications (do not treat), relative contraindications (require medical clearance or modification), and conditions requiring monitoring.

  • Pregnancy or breastfeeding: Absolute contraindication. Chemical peel ingredients (glycolic acid, TCA) are not proven safe in pregnancy; systemic absorption risk is low but unknown. Advise deferring treatment until after breastfeeding ceases.
  • Current isotretinoin (Accutane) use: Absolute contraindication. Accutane causes severe skin fragility and prolonged healing. Require 6-12 month washout before peels.
  • Current tretinoin (Retin-A) or adapalene (Differin): Relative contraindication. These increase peel sensitivity and erythema. Patients should discontinue 7-14 days before treatment and resume aftercare only.
  • Active herpes simplex or cold sores: Relative contraindication. Chemical peels can trigger herpes outbreaks in susceptible patients. Consider prophylactic antivirals (acyclovir) before treatment.
  • Recent facial procedures (laser, filler, microdermabrasion): Relative contraindication. Skin sensitivity is elevated; require 2-4 week intervals between procedures.
  • Darker skin types (Fitzpatrick IV-VI): Relative contraindication for deeper peels. Higher risk of post-inflammatory hyperpigmentation. Recommend superficial glycolic or lactic acid peels with extended sun protection and hydroquinone use post-peel if hyperpigmentation emerges.

Document each contraindication check in the consent form. Have patients initial each item to confirm they were screened and that they disclosed any relevant history.

Conclusion

A chemical peel consent form is your clinic’s first line of defense against liability and your patient’s key to understanding procedure risks and recovery expectations. A well-designed form screens contraindications, documents informed consent, and clarifies aftercare so both practitioner and patient can proceed with confidence.

Manually managing printed forms creates filing delays, compliance gaps, and lost documents. Pabau’s digital forms and e-signature features let you deliver the consent form electronically, collect it securely, and store it with full GDPR compliance and audit trails. Book a demo to see how your clinic can streamline consent workflows today.

Continue your research

Continue your research

Want a structured template for initial skin consultations? How to prepare for cosmetic client consultation walks through pre-treatment consultation best practices and intake form design.

Need guidance on storing patient data securely? HIPAA compliance for clinic software covers encryption, access controls, and audit logs for protecting signed consent documents.

Running a med spa and want to automate patient communications? Medical spa software integrates digital forms, e-signatures, and automated aftercare reminders into one platform.

Frequently Asked Questions

What is a chemical peel consent form?

A chemical peel consent form is a signed document confirming the patient understands the procedure’s risks, benefits, contraindications, and aftercare requirements. It protects both the clinic and the patient by documenting informed consent before treatment.

Is a chemical peel consent form legally required?

Yes. The American Society of Plastic Surgeons (ASPS) requires informed consent for all aesthetic procedures. UK clinics are subject to CQC and ICO regulations requiring documented consent. State licensing boards (US) and professional bodies (ASCP, JCCP) also mandate consent documentation.

What are the main risks to disclose in a chemical peel consent form?

The form must disclose redness (erythema), flaking and peeling, post-inflammatory hyperpigmentation (especially in darker skin types), temporary sensitivity to sunlight, infection risk if aftercare is not followed, and the possibility of scarring with deeper peels. Specific risks depend on peel depth and skin type.

How long should a patient stop tretinoin before a chemical peel?

Patients using tretinoin (Retin-A) should discontinue the product 7-14 days before chemical peel treatment to reduce peel sensitivity and irritation. They may resume gentle use after healing is complete, typically 1-2 weeks post-peel.

Can I store digital consent forms safely under GDPR?

Yes. The UK ICO requires that signed consent forms be stored securely with appropriate technical and organisational safeguards. Use clinic software with encryption, access controls, and audit logs (e.g., Pabau’s compliance management features) to meet GDPR requirements for patient data protection.

Should I use different consent forms for superficial vs. deep chemical peels?

Yes. A superficial peel (glycolic, lactic acid) carries lower risk and shorter recovery. A medium-depth peel (TCA) has higher hyperpigmentation risk and longer downtime. A deep peel (phenol) carries scarring risk and requires extended recovery. Customize the form to reflect the specific peel type being performed.

×